ImaginAB Gets $12.8M

Los Angeles-based ImaginAb, a biotechnology company which is developing radiopharmaceutical imaging and therapy agents, has raised $12.8M in a funding round, the company said on Thursday. According to the company, the funding was led by Adage Capital and Cycad Group and also included new investors Norgine Ventures and Theravance Respiratory Company, along with current investor Jim Pallotta of the Raptor Group. ImaginAb is led by CEO Ian Wilson.